NEW YORK, March 1, 2016 /PRNewswire/ -- Summary
Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world's leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin. Through their ability to address a number of clinical demands, acellular dermal matrices are positioned to benefit as the global market matures.
- What are the key segments and patient demographics that comprise the market for engineered wound care?
- What are the major therapeutic demand drivers for acellular dermal matrices?
- What are the design factors, material selection issues and technologies that are being used in commercial and development-stage dermal matrix products?
- What is the market share and product position in the market and what will it look like in 2020?
- Who are the companies behind the current generation of engineered wound care products and what are their business models?
- What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging engineered wound therapies?
- What is the impact of economic, technology, and regulatory factors?
Read the full report: http://www.reportlinker.com/p03620312-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001